A promising young Ultimate Fighting Championship heavyweight has just hit a huge snag in his career.
Advertisement
On Friday, the U.S. Anti-Doping Agency announced that Hamdy Abdelwahab failed a post-fight drug test on July 30, 2022, for methenolone, an anabolic steroid. Additionally, before USADA notified him of his failure, they tested him again on August 27 of that year, and once more he had methenolone in his system. Due to the lack of notification on USADA’s end, the two failed tests will be considered one violation, and he will receive a two-year suspension effective the July test date.Abdelwahab made his debut on short notice at UFC 277 on July 30, and he defeated Don'Tale Mayes by split decision in a thriller. The agency requires that fighters entering the testing pool disclose any substances they have taken in the last year, so that they can sit out until testing clean without suffering a penalty. If fighters do not disclose a substa…